122 related articles for article (PubMed ID: 25109993)
1. Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier.
Dias IH; Polidori MC; Griffiths HR
Biochem Soc Trans; 2014 Aug; 42(4):1001-5. PubMed ID: 25109993
[TBL] [Abstract][Full Text] [Related]
2. Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress.
de Oliveira J; Hort MA; Moreira EL; Glaser V; Ribeiro-do-Valle RM; Prediger RD; Farina M; Latini A; de Bem AF
Neuroscience; 2011 Dec; 197():99-106. PubMed ID: 21945034
[TBL] [Abstract][Full Text] [Related]
3. Oxidised LDL lipids, statins and a blood-brain barrier.
Griffiths H; Irundika D; Lip G; Spickett C; Polidori C
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S15-6. PubMed ID: 26461292
[TBL] [Abstract][Full Text] [Related]
4. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
[TBL] [Abstract][Full Text] [Related]
5. Increased susceptibility to amyloid-β-induced neurotoxicity in mice lacking the low-density lipoprotein receptor.
de Oliveira J; Moreira EL; dos Santos DB; Piermartiri TC; Dutra RC; Pinton S; Tasca CI; Farina M; Prediger RD; de Bem AF
J Alzheimers Dis; 2014; 41(1):43-60. PubMed ID: 24577472
[TBL] [Abstract][Full Text] [Related]
6. Statins of different brain penetrability differentially affect CSF PLTP activity.
Vuletic S; Riekse RG; Marcovina SM; Peskind ER; Hazzard WR; Albers JJ
Dement Geriatr Cogn Disord; 2006; 22(5-6):392-8. PubMed ID: 16960448
[TBL] [Abstract][Full Text] [Related]
7. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
da Silva PM
Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of blood cholesterol, mechanism of hypercholesterolemia].
Luc G; Douste-Blazy P; Fruchart JC
Rev Prat; 1989 Apr; 39(12):1019-22. PubMed ID: 2740766
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Improves High-Density Lipoprotein Function in Patients With Hypercholesterolemia: A Double-Blinded, Randomized, and Placebo-Controlled Trial.
Song G; Lin Q; Zhao H; Liu M; Ye F; Sun Y; Yu Y; Guo S; Jiao P; Wu Y; Ding G; Xiao Q; Qin S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2724-33. PubMed ID: 25978109
[TBL] [Abstract][Full Text] [Related]
10. Oxysterols and Alzheimer's disease.
Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
[TBL] [Abstract][Full Text] [Related]
11. Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors.
Kang J; Rivest S
Endocr Rev; 2012 Oct; 33(5):715-46. PubMed ID: 22766509
[TBL] [Abstract][Full Text] [Related]
12. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
Yoshida H
Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
[TBL] [Abstract][Full Text] [Related]
13. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
14. Age-related cognitive decline in hypercholesterolemic LDL receptor knockout mice (LDLr-/-): evidence of antioxidant imbalance and increased acetylcholinesterase activity in the prefrontal cortex.
Moreira EL; de Oliveira J; Nunes JC; Santos DB; Nunes FC; Vieira DS; Ribeiro-do-Valle RM; Pamplona FA; de Bem AF; Farina M; Walz R; Prediger RD
J Alzheimers Dis; 2012; 32(2):495-511. PubMed ID: 22810096
[TBL] [Abstract][Full Text] [Related]
15. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
[TBL] [Abstract][Full Text] [Related]
16. LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease.
Cagnin A; Leon A; Vianello D; Colavito D; Favaretto S; Zarantonello G; Stecca A; Ermani M; Zambon A
J Alzheimers Dis; 2013; 34(2):377-85. PubMed ID: 23207490
[TBL] [Abstract][Full Text] [Related]
17. Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.
Viigimaa M; Abina J; Zemtsovskaya G; Tikhaze A; Konovalova G; Kumskova E; Lankin V
Blood Press; 2010 Jun; 19(3):164-8. PubMed ID: 20429692
[TBL] [Abstract][Full Text] [Related]
18. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
Gosselet F; Saint-Pol J; Fenart L
Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.
Poirier J
Neurobiol Aging; 2005 Mar; 26(3):355-61. PubMed ID: 15639314
[TBL] [Abstract][Full Text] [Related]
20. Curcuma oil ameliorates hyperlipidaemia and associated deleterious effects in golden Syrian hamsters.
Singh V; Jain M; Misra A; Khanna V; Rana M; Prakash P; Malasoni R; Dwivedi AK; Dikshit M; Barthwal MK
Br J Nutr; 2013 Aug; 110(3):437-46. PubMed ID: 23673139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
